In-house research and development (R&D) of APIs and drug products are important facets of Synthon's vertically integrated organization. Our success depends on the sustainable growth of our business through research into and development of valuable additions to our product portfolio. We are continuously seeking to raise the bar in terms of competitiveness in this area.
Synthon has implemented this systematic approach to development, emphasizing product and process understanding and process control. QbD is based on sound science and quality risk management, allowing for continual improvement and innovation and leading to cost reduction and efficiency improvements.